With a total of 200 shares trading on the S&P/ASX 200 Index (ASX: XJO), there certainly is a lot of choice for investors.
Among the many quality options on the benchmark index, I think the three listed below are standout picks right now.
Here’s why I would invest $3,000 across these ASX 200 shares:
Appen Ltd (ASX: APX)
The first ASX 200 share I would buy is Appen. It is a leading developer of high-quality, human annotated datasets for the machine learning and artificial intelligence (AI) markets. This essentially means that it prepares the data that goes into AI models. This is a vital part of the process, as quality data is integral to improving models and allowing them to reach their full potential. Pleasingly, with spending on machine learning and AI expected to grow materially over the next decade, Appen looks well-placed to benefit. Especially given its leadership position in the market and its history of working with tech giants such as Apple, Facebook, and Microsoft.
CSL Limited (ASX: CSL)
Another ASX 200 share to buy is CSL. I think the biotherapeutics giant could be the highest quality company on the index and a great long term option. This is due to its world class therapies and vaccines, high level of investment in research and development, expansive plasma collection network, and talented management team. Combined, I believe they leave CSL well-positioned to deliver solid earnings growth over the 2020s.
SEEK Limited (ASX: SEK)
A final ASX 200 share to buy is SEEK. Due to its growing China-based operations and its market domination in the ANZ market, I believe SEEK is well-positioned for long term growth once the pandemic passes. Management certainly appears to believe this is the case. It continues to target revenue of $5 billion later this decade. This will be a very big increase on the revenue of $1,577.4 million it recorded in FY 2020.
These 3 stocks could be the next big movers in 2020
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- ASX 200 up 0.95%: Big four banks rise, Scentre collections improve, Nufarm jumps
- ASX investors given a $1.7bn injection of COVID-19 hope
- Why I would buy Appen and these ASX tech shares after the selloff
- ASX 200 rises 0.3%, CSL reveals COVID-19 vaccine manufacturing deals
- Broker picks best ASX small cap stocks to buy from the reporting season
James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended SEEK Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post 3 ASX 200 shares to buy with $3,000 this week appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2ZgnwOB
Leave a Reply